PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32927467-2	2020	We determined the diagnostic and prognostic value of IGF1 and IGFBP2 in pediatric PAH.	p-Aminohippuric Acid	82-85	insulin like growth factor 1	Homo sapiens	53-57	
9574462-5	1998	Treatment with IGF-I (60 mg/kg twice daily sc) for 31 days resulted in a 14% and 18% increase in the inulin and PAH clearances respectively (n = 6 patients).	p-Aminohippuric Acid	112-115	insulin like growth factor 1	Homo sapiens	15-20	
8498545-7	1993	Administration of rhIGF-I increased levels of circulating IGF-I, inulin clearances, PAH clearances, and kidney size in each of the four patients receiving the growth factor.	p-Aminohippuric Acid	84-87	insulin like growth factor 1	Homo sapiens	20-25	
2240230-2	1990	Administration of either bGH (100-200 micrograms/day) or hIGF-I (200 micrograms/day) to rats with normal renal mass increased inulin and p-aminohippurate clearances compared with those measured in animals that received vehicle.	p-Aminohippuric Acid	139-153	insulin like growth factor 1	Homo sapiens	57-63	
32927467-13	2020	: a IGF1 concentration (ng/mL) in PAH Biobank versus asthmatic subjects.	p-Aminohippuric Acid	34-37	insulin like growth factor 1	Homo sapiens	4-8